Pfizer has announced it’s agreed to a deal that promises to lower most of its prescription drug prices.
The drugmaker, whose biggest manufacturing plant is in Portage, is the first to agree to terms set forth in a letter sent by President Trump to pharmaceutical companies in June.
The deal will see Pfizer sell drugs to Medicaid and Medicare at discounted prices. It’ll also allow them to sell drugs direct to consumers via TrumpRx, a new website President Trump announced earlier this week as part of the deal.
In response, Pfizer said it plans to boost its domestic manufacturing and offer discounts ranging from 50-85% on most primary care treatments and some specialty brands.
The TrumpRx website is set to launch in January of 2026. In an email, Pfizer declined a request for comment but said it would share more information in the coming months.
